Literature DB >> 24468071

Coexisting diseases of moyamoya vasculopathy.

Yi-Chia Wei1, Chi-Hung Liu2, Ting-Yu Chang2, Shy-Chyi Chin3, Chien-Hung Chang4, Kuo-Lun Huang2, Yeu-Jhy Chang2, Tsung-I Peng1, Tsong-Hai Lee5.   

Abstract

BACKGROUND: Several coexisting diseases have been reported in patients with moyamoya vasculopathy (MMV), but studies of quasi-moyamoya disease (quasi-MMD) are rare. This study aims to investigate the frequency of known coexisting diseases in patients with quasi-MMD and to compare quasi-MMD with moyamoya disease (MMD).
METHODS: Between 2000 and 2011, we retrospectively screened patients with International Classification of Diseases, Ninth Revision, code of 4375 (MMD) in the Health Information System of our hospital. The vascular images of each patient were confirmed by 2 neurologists and 1 neuroradiologist based on the diagnostic criteria of Japan Ministry of Health and Welfare. We excluded the patients with missing images and erroneous diagnosis. Demographics, coexisting diseases, laboratory data, treatment, and recurrent strokes were recorded. The eligible patients were divided into quasi-MMD and MMD groups according to the presence or absence of coexisting diseases.
RESULTS: MMV was found in 90 patients including 37 (41.1%) quasi-MMD and 53 (58.9%) MMD. Atherosclerosis (32.4%) and thyroid disease (29.7%) were the leading coexisting diseases in quasi-MMD. Patients with MMD became symptomatic in a bimodal age distribution, whereas patients with quasi-MMD became symptomatic in a single-peak distribution. The prognosis of recurrent strokes was similar between quasi-MMD and MMD based on Kaplan-Meier analysis.
CONCLUSIONS: A bimodal distribution of onset age was noted in MMD, whereas a single-peak distribution was found in quasi-MMD. Coexisting diseases were usually underevaluated but were more common than expected in patients with MMV. Atherosclerosis and thyroid diseases were the leading coexisting diseases in different preferential age.
Copyright © 2014 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Moyamoya disease; Taiwan; atherosclerosis; hyperthyroidism; moyamoya syndrome; moyamoya vasculopathy; quasi-moyamoya disease; stroke

Mesh:

Year:  2014        PMID: 24468071     DOI: 10.1016/j.jstrokecerebrovasdis.2013.11.008

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  6 in total

1.  Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Authors:  Mahmud Mossa-Basha; Adam de Havenon; Kyra J Becker; Danial K Hallam; Michael R Levitt; Wendy A Cohen; Daniel S Hippe; Matthew D Alexander; David L Tirschwell; Thomas Hatsukami; Catherine Amlie-Lefond; Chun Yuan
Journal:  Stroke       Date:  2016-06-07       Impact factor: 7.914

Review 2.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

3.  Specific Shrinkage of Carotid Forks in Moyamoya Disease: A Novel Key Finding for Diagnosis.

Authors:  Satoshi Kuroda; Daina Kashiwazaki; Naoki Akioka; Masaki Koh; Emiko Hori; Manabu Nishikata; Kimiko Umemura; Yukio Horie; Kyo Noguchi; Naoya Kuwayama
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-09-15       Impact factor: 1.742

4.  Moyamoya Disease with Coexistent Hypertriglyceridemia in Pediatric Patient.

Authors:  Jacqueline Chan; Fabiola D'Ambrosio Rodriguez; Deepank Sahni; Claudia Boucher-Berry
Journal:  Case Rep Endocrinol       Date:  2016-10-24

5.  Influence of Autologous Bone Marrow Stem Cell Therapy on the Levels of Inflammatory Factors and Conexin43 of Patients with Moyamoya Disease.

Authors:  Liming Zhao; Tianxiao Li; Bingqian Xue; Hao Liang; Shao Zhang; Ruiyu Wu; Gaochao Guo; Tao Gao; Yang Liu; Yuxue Sun; Chaoyue Li
Journal:  Comput Intell Neurosci       Date:  2022-08-23

6.  Moyamoya and progressive myoclonic epilepsy secondary to CLN6 bi-allelic mutations - A previously unreported association.

Authors:  Jamie Talbot; Priyanka Singh; Clinda Puvirajasinghe; Sanjay M Sisodiya; Fergus Rugg-Gunn
Journal:  Epilepsy Behav Rep       Date:  2020-08-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.